The study included patients treated in a neurological intensive care unit and serum levels of C-reactive protein and S–PCT were evaluated on admission day, on the day of diagnosis of SIRS or sepsis, and on days three and seven after the diagnosis. The gene discussed is CALCA; the disease is Sepsis.